Life Science Company News

Results 81 - 100 out of 500 displayed.
«  1  2  3  4 5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Trevena Announces Initial Topline OLINVYK Data from ~200 Patient Real-World Clinical Outcomes Study

Read more ››
By: GlobenewsWire - 30 Mar 2023

GSK and SCYNEXIS Announce an Exclusive Agreement to Commercialise and Further Develop Brexafemme (ibrexafungerp), a Novel, First-in-Class Medicine to Treat Fungal Infection

Read more ››
By: GlobenewsWire - 30 Mar 2023

Combination between Novozymes and Chr. Hansen approved by the Novozymes shareholders

Read more ››
By: GlobenewsWire - 30 Mar 2023

Combination between Novozymes and Chr. Hansen approved by Novozymes’ shareholders

Read more ››
By: GlobenewsWire - 30 Mar 2023

Resolutions from Novozymes A/S’ Extraordinary Shareholders’ Meeting on 30 March 2023

Read more ››
By: GlobenewsWire - 30 Mar 2023

CorMedix Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Read more ››
By: GlobenewsWire - 30 Mar 2023

XOMA Acquires Cashflow-Generating Asset for its Royalty and Milestone Portfolio

Read more ››
By: GlobenewsWire - 30 Mar 2023

Zevra Therapeutics Appoints Biopharma Veteran Wendy Dixon, Ph.D., to Board of Directors

Read more ››
By: GlobenewsWire - 30 Mar 2023

Sensei Biotherapeutics to Participate in Cantor Fitzgerald’s Future of Oncology Virtual Symposium

Read more ››
By: GlobenewsWire - 30 Mar 2023

Atlas Global Brands to Participate in Benzinga Cannabis Capital Conference

Read more ››
By: GlobenewsWire - 30 Mar 2023

Reviva Pharmaceuticals Holdings, Inc. Reports Full Year 2022 Financial Results and Recent Business Highlights

Read more ››
By: GlobenewsWire - 30 Mar 2023

VYNE Therapeutics Announces Positive First-In-Human Pharmacokinetic and Hematology Data from Phase 1a Single and Multiple Ascending Dose Trial for Novel Pan-Bromodomain BET Inhibitor VYN201

Read more ››
By: GlobenewsWire - 30 Mar 2023

aTyr Pharma Announces First Major Review Article for Efzofitimod Published in the Journal Sarcoidosis, Vasculitis and Diffuse Lung Diseases

Read more ››
By: GlobenewsWire - 30 Mar 2023

Ocuphire Pharma Announces Financial Results for Fourth Quarter and Year Ended 2022 and Provides Corporate Update

Read more ››
By: GlobenewsWire - 30 Mar 2023

Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq

Read more ››
By: GlobenewsWire - 30 Mar 2023

Avalyn Pharma Reports Results of Phase 1 Study of AP02 in Healthy Volunteers and Participants with Idiopathic Pulmonary Fibrosis

Read more ››
By: GlobenewsWire - 30 Mar 2023

Immutep Announces Expansion of Triple Combination Therapy in 1st Line Non-Small Cell Lung Cancer

Read more ››
By: GlobenewsWire - 30 Mar 2023

Daré Bioscience Reports Full Year 2022 Financial Results and Provides a Company Update

Read more ››
By: GlobenewsWire - 30 Mar 2023

Femasys Inc. Announces Financial Results for the Year Ended December 31, 2022 and Provides Corporate Update

Read more ››
By: GlobenewsWire - 30 Mar 2023

Sight Sciences Defeats Invalidity Challenges Filed By Alcon and Ivantis In The U.S. Patent Office

Read more ››
By: GlobenewsWire - 30 Mar 2023
Results 81 - 100 out of 500 displayed.
«  1  2  3  4 5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate